FDA Investigator Daniel S Fam

Daniel S Fam has conducted inspections on 86 sites in 5 countries as of 22 Oct 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
22 Oct 2014
Investigator Role:
FDA Investigator
Redica ID:
100005204
Countries of Inspections:
United States of America, Germany, China, Israel, Japan
FDA Investigators that have inspected at least one site in common with Daniel S Fam:
Adam C Hipko, Adrian Rodriguez, Akbar J Zaidi, Alcee M Tavarez, Amanda J White, Andrea A Branche, Andrew J Lang, Angela Mock, Anh M Lac, Anya Dlockett Evans, Arie R Dyk, Ashley N Williams, Betsy C Galliher, Bing Lin, Blondell W Johnson, Brackens Harris, Brandi E Williams, Brenda G Stewart Munoz, Brian R Yaun, Brian Sanders, Brook Shea, Camille D Brown, Carol A Declouette Wilburn, Casey L Hamblin, Cassandra L Abellard, Cathleen A Castellaw, CDR Sean T Creighton, Chad J Whitwell, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher K Gibbs, Christopher L Jacobs, Cindy J Jeffrey, Connie L Hannon Rabel, Constance M Dobbins, Crystal S Harris, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Damaris Y Hernandez, Dana M Lewis, Daniel J Lahar, Danielle Lyke, Danny D Horner, Dawn P Hall, Denise Connelly, Deniza Karacic, Dolores Harper, Ed Gonzalez Vazquez, Edward D Edmiston, Elisa M Fleming, Ellen J Kleintop, Ellen J Tave, Enspect User, Erick G Marchan, Ernest Serna, III, Fernando C Martinez, Florecia S Philogene, Frank J Marciniak, Frans E Mercado, Gilbert Valdez, RS, Grant L Davis, Hung V Le, Iris C Macinnes, J Elkins, Jacob W Reynolds, Jamie M Bumpas, Janet B Abt, Janet Pulver, Janice M Hickok, Jd Young, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jennifer O Dowdy, Jeremy L Stukes, Jeremy R Read, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, Johnson, Jonathan A Womack, Joy L Ramsey, Karen M Rodriguez, Karlton T Watson, Kathleen Chmura Shaffer, Kayla R Deatherage, Kelly D Sheppard, Kenitra D Hewitt, Kunapuli T Madhusudhan, L Grant, Lance D Johnson, Lauren E Skokan, Leighton Kn Gai, Lisa M Puttonen, Lisa R Jennings, Liza L Quiles, Lloyd D Payne, Lourdes R Genera, Maira P Brading, Marc R Dickens, Margaret M Annes, Margarito J Uribe, Martha S Baldwin, Micmarie Ramos Rodriguez, Mildred H Glasgow, Monica J Wilkins, Monique Rac Lester, Monique S Frazier, Nancy L Neiger, Ninfa N Innocent, Olalere D Fasipe, Osama A Khatib, Patrick D Stone, MS, Paul E Frazier, Paul M Chefor, Paul W Moy, Pauline N Logan, Philip M Steele, PhD, Phillip J Sample, Phillip M Pontikos, Quynh Anh H Tran, Rebecca Co Bryan, Rendall E Barfoot, Rene R Ramirez, Renee Johnson, RS, Rhonda L Dash, Richard Jay Tucker, RS, Robert M Tillman, Robert T Harris, Robert T Lorenz, Roy Baby, Roy Hendley, Saijal P Naik, Samuel A Hamblin, Samuel J Arsenault, Sandy J Ziegler, Sarah Forney, Sarah L Fredric, Scott R Nichols, PhD, Scott T Ballard, Sean M Cheney, Selina M Mata, Sha'tina R Alridge, Shannon A Lowe, Shawn E Larson, Sherrie L Krolczyk, Staci G Mcallister, Stephen R Souza, Susan M Matthias, Tamera H Hunt, Tara A Gray, Terri E Gibson, Thai T Duong, Toby Vern H Hill, Tricia S Martinez, Trina K Vick, Tuan A Nguyen, William H Shackelford, Yaw O Osei, Young M Yoon, Yvette Mlacour Davis, Zumera B Ajani

Daniel S Fam's Documents

Publish Date Document Type Title
January, 2014 FDA 483 Electro Medical, Inc. - Form 483, 2014-01-16
October, 2014 EIR Oxysure Systems, Inc. - EIR, 2014-10-03
June, 2012 FDA 483 Coca-Cola Refreshments USA, Inc. - Form 483, 2012-06-05
August, 2014 FDA 483 LivaNova USA, Inc. - Form 483, 2014-08-22
December, 2013 FDA 483 BTI Filtration - Form 483, 2013-12-12
April, 2013 FDA 483 OriGen Biomedical, Inc. - Form 483, 2013-04-26
July, 2013 FDA 483 Estill Medical Technologies, Inc - Form 483, 2013-07-03
November, 2012 FDA 483 RX Air Industries LLC. - Form 483, 2012-11-19
March, 2013 FDA 483 Virtex - Form 483, 2013-03-26
October, 2014 FDA 483 Oxysure Systems, Inc. - Form 483, 2014-10-03
March, 2013 FDA 483 Ideal Implant Incorporated - Form 483, 2013-03-01
October, 2014 FDA 483 Response Oxysure Systems, Inc. - Form 483R, 2014-10-24
May, 2014 FDA 483 TP Orthodontic Appliance (Wuxi) Co., Ltd. - Form 483, 2014-05-08
January, 2013 FDA 483 SpineSmith Holdings, LLC - Form 483, 2013-01-31
March, 2013 FDA 483 Consolidated Technologies, Inc. - Form 483, 2013-03-29
August, 2013 FDA 483 Retractable Technologies, Inc. - Form 483, 2013-08-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more